home / United States / Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Market Cap

$29.89 B

-1.18 B

NASDAQ:ALNY · April 16, 2025

Share price

$230.93

Enterprise Value

$31.12 B

Change (1-Year)

88.6%

Global Rank

#647

Country Rank

#281

Regions

USA

Market cap

As of April 16, 2025, Alnylam Pharmaceuticals (ALNY) has a market cap of $29.89 billion USD. According to our data, Alnylam Pharmaceuticals is ranked No.647 in global market value.

Sector Rank:

Biotech #30 Pharmaceuticals #30

ALNY Market Capitalization Growth

1 Years Growth:

88.6%

3 Years Growth:

74.9%

5 Years Growth:

97.9%

10 Years Growth:

134.3%

15 Years Growth:

1513.1%

20 Years Growth:

3226.0%

Total Growth:

3816%

Alnylam Pharmaceuticals Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Alnylam Pharmaceuticals Market Cap CAGR Chart

Alnylam Pharmaceuticals Market Cap History 2004 - 2025

Year	Market Cap	%Change
Apr 16, 2025	$29.89 B	-1.52%
Dec 31, 2024	$30.35 B	22.94%
Dec 29, 2023	$24.69 B	-19.46%
Dec 30, 2022	$30.65 B	40.14%
Dec 31, 2021	$21.87 B	30.48%
Dec 31, 2020	$16.76 B	12.85%
Dec 31, 2019	$14.85 B	57.96%
Dec 31, 2018	$9.40 B	-42.61%
Dec 29, 2017	$16.39 B	239.34%
Dec 30, 2016	$4.83 B	-60.23%
Dec 31, 2015	$12.14 B	-2.95%
Dec 31, 2014	$12.51 B	50.86%
Dec 31, 2013	$8.29 B	252.33%
Dec 31, 2012	$2.35 B	123.93%
Dec 30, 2011	$1.05 B	-17.34%
Dec 31, 2010	$1.27 B	-44.04%
Dec 31, 2009	$2.27 B	-28.75%
Dec 31, 2008	$3.19 B	-14.96%
Dec 31, 2007	$3.75 B	35.89%
Dec 29, 2006	$2.76 B	60.66%
Dec 30, 2005	$1.72 B	78.31%
Dec 31, 2004	$0.96 B	100%

Similar Companies to Alnylam Pharmaceuticals

Name	Market Cap	Market cap difference	Regions
Eli Lilly LLY	$679.94 B	-0.022 M	USA
Johnson & Johnson JNJ	$370.20 B	0.003 M	USA
AbbVie ABBV	$312.76 B	-0.013 M	USA
Novo Nordisk NVO	$286.98 B	70.023 B	Denmark
Novo Nordisk A/S NOVO-B.CO	$285.97 B	64.050 B	Denmark
Roche ROG.SW	$249.63 B	38.060 B	Switzerland
Novartis NVS	$217.12 B	0.003 M	Switzerland
AstraZeneca AZN	$210.42 B	-0.005 M	UK
Merck MRK	$197.26 B	0.003 M	USA
Thermo Fisher Scientific TMO	$166.47 B	0.002 M	USA
Amgen AMGN	$158.77 B	0.132 B	USA
Gilead Sciences GILD	$131.74 B	-0.002 M	USA
Vertex Pharmaceuticals VRTX	$128.67 B	-0.003 M	USA
Pfizer PFE	$127.27 B	-0.003 M	USA
Sanofi SNY	$123.58 B	-0.002 M	France
Bristol-Myers Squibb BMY	$101.74 B	-0.001 M	USA
CVS Health CVS	$87.00 B	-0.003 M	USA
Chugai Pharmaceutical 4519.T	$77.18 B	0.794 B	Japan
CSL CSL.AX	$74.79 B	-0.212 B	Australia
GlaxoSmithKline GSK	$72.33 B	-0.002 M	UK

About Alnylam Pharmaceuticals Inc.

Name

Alnylam Pharmaceuticals, Inc.

Website

https://www.alnylam.com

Headquarters

Cambridge,MA

symbol

ALNY

CURRENCY

USD

country

United States

fullTimeEmployees

2230

exchange

NMS

firstTradeDateEpochUtc

1969/12/31

ALNY Market Cap Formula

Market Cap	=	ALNY Stock Price	*	ALNY Shares Outstanding
	=	$230.93	*	0.13 B
	=	$29.89 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe